Dutch start-up VectorY Therapeutics has been given the green light by the FDA for a phase 1/2 trial of a drug against a target implicated in up to 97% of amyotrophic lateral sclerosis (ALS) cases. VTx ...
Editor's note: Eric Dane died on Feb. 19, 2026, after battling ALS, a progressive neurological disease. He shared the news of his diagnosis in April 2025 and became a public advocate for research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results